HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/1/E114    most recent 00134.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Thulé, P. M. Articles by Hart, C. M. Search for Related Content PubMed PubMed Citation Articles by Thulé, P. M. Articles by Hart, C. M.

Hepatic insulin gene therapy prevents deterioration of vascular function and improves adipocytokine profile in STZ-diabetic rats

¹Endocrinology and Metabolism Section and ²Pulmonary and Critical Care Section, Atlanta Veterans Affairs Medical Center and Emory University, Decatur, Georgia

Submitted 24 March 2005 ; accepted in final form 17 August 2005

Hepatic insulin gene therapy (HIGT) ameliorates hyperglycemia in diabetic rodents, suggesting that similar approaches may eventually provide a means to improve treatment of diabetes mellitus. However, whether the metabolic and hormonal changes produced by HIGT benefit vascular function remains unclear. The impact of HIGT on endothelium-dependent vasodilation, nitrosyl-hemoglobin content (NO-Hb), and insulin sensitivity were studied using aortic ring preparations, electron spin resonance spectroscopy (ESR), homeostasis assessment of insulin resistance (HOMA-IR) calculations, and insulin tolerance testing (ITT). Data were correlated with selected hormone and adipocytokine concentrations. Rats made diabetic with streptozotocin were treated with subcutaneous insulin pellets dosed to sustain body weights and hyperglycemia or with HIGT; nondiabetic rats served as controls. Hyperglycemic rats demonstrated impaired endothelium-dependent vasodilation, reduced levels of NO-Hb, and diminished insulin, leptin, and adiponectin concentrations compared with controls. In contrast, HIGT treatment significantly reduced blood sugars and sustained both endothelium-mediated vasodilation and NO-Hb at control levels. HOMA-IR calculations and ITT indicated enhanced insulin sensitivity among HIGT-treated rats. HIGT partially restored suppressed leptin levels in hyperglycemic rats and increased adiponectin concentrations to supranormal levels, consistent with indicators of insulin sensitivity. Our findings indicate that the metabolic milieu produced by HIGT is sufficient to preserve vascular function in diabetic rodents. These data suggest that improved glycemia, induction of a beneficial adipocytokine profile, and enhanced insulin sensitivity combine to preserve endothelium-dependent vascular function in HIGT-treated diabetic rats. Consequently, HIGT may represent a novel and efficacious approach to reduce diabetes-associated vascular dysfunction.

adenovirus; adiponectin; endothelium; diabetes mellitus; streptozotocin

This article has been cited by other articles:

				R. E. Nisbet, A. S. Graves, D. J. Kleinhenz, H. L. Rupnow, A. L. Reed, T.-H. M. Fan, P. O. Mitchell, R. L. Sutliff, and C. M. Hart The Role of NADPH Oxidase in Chronic Intermittent Hypoxia-Induced Pulmonary Hypertension in Mice Am. J. Respir. Cell Mol. Biol., May 1, 2009; 40(5): 601 - 609. [Abstract] [Full Text] [PDF]

				C. X. Zhao, X. Xu, Y. Cui, P. Wang, X. Wei, S. Yang, M. L. Edin, D. C. Zeldin, and D. W. Wang Increased Endothelial Nitric-Oxide Synthase Expression Reduces Hypertension and Hyperinsulinemia in Fructose-Treated Rats J. Pharmacol. Exp. Ther., February 1, 2009; 328(2): 610 - 620. [Abstract] [Full Text] [PDF]

				M. J. Holness, G. K. Greenwood, N. D. Smith, and M. C. Sugden PPAR{alpha} activation and increased dietary lipid oppose thyroid hormone signaling and rescue impaired glucose-stimulated insulin secretion in hyperthyroidism Am J Physiol Endocrinol Metab, December 1, 2008; 295(6): E1380 - E1389. [Abstract] [Full Text] [PDF]

				J. Cacho, J. Sevillano, J. de Castro, E. Herrera, and M. P. Ramos Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1269 - E1276. [Abstract] [Full Text] [PDF]

				M. J. Holness, N. D. Smith, G. K. Greenwood, and M. C. Sugden PPAR{alpha} activation reverses adverse effects induced by high-saturated-fat feeding on pancreatic beta-cell function in late pregnancy Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E1087 - E1094. [Abstract] [Full Text] [PDF]